The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 265.00
Bid: 260.00
Ask: 270.00
Change: 0.00 (0.00%)
Spread: 10.00 (3.846%)
Open: 265.00
High: 265.00
Low: 265.00
Prev. Close: 265.00
CRPR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual General Meeting and Trading Update

31 Jul 2013 11:00

RNS Number : 5858K
Cropper(James) PLC
31 July 2013
 



31 July 2013

James Cropper PLC ("James Cropper" or the "Company")

 

Annual General Meeting and Trading Update

 

At the Company's AGM held at 11.00am today, Mark Cropper, Chairman, made the following statement:

 

"I am pleased to report that the Group has traded profitably in the first quarter of the new financial year in line with management expectations".

 

"James Cropper Speciality Papers ("Speciality Papers") has started the year well, with total sales in the quarter up 13% on the comparable period last year. Overall volume was up 16%, with export volumes up 20%".

 

"The cost of Northern Bleached Softwood Kraft virgin wood-pulp started the year at US$830/tonne and had risen to US$860/tonne at 30th June 2013. Some market analysts believe that the price of pulp has now peaked and will fall during the remainder of 2013, before increasing again in early 2014. Fibre extracted from Speciality Papers' innovative Reclaimed Fibre plant currently represents an average pulp substitution rate of approximately 10% in our overall production. This fibre is extremely high quality which makes it an ideal substitute for pulp as well as mitigating the impact of pulp price volatility. It is intended that the level of overall substitution by the end of the current financial year will be in the region of 13%".

 

"Sales in Technical Fibre Products were slightly down on the comparable period in 2012 primarily due to the timing of sales into the Defence sector. We expect to see growth in this sector over the full year and are currently on-track to achieve this".

 

"James Cropper Converting traded ahead of the first quarter of last year as demand for launch stocks of Digital Printing and Art & Framing products into the USA led to a c.30% increase in sales. This increased sales level is not expected to be sustained for the remainder of the year."

 

"Export markets are very important to us, representing 49% of total turnover in the past financial year. It was very pleasing that across the Group sales into the USA were up 24%, offsetting the 12% decline in sales into continental Europe. Given the progress we have recently made I anticipate that in the current financial year all of our businesses will make further gains in their export markets".

 

"Increasing substitution of virgin wood-pulp with re-cycled pulp from our Reclaimed Fibre facility is also expected to improve margins on some of our products in Speciality Papers in the coming years".

 

"Although global economic factors remain challenging I am confident that the plans being formulated and deployed under Phil Wild's leadership will deliver growth in profits".

 

Mark Cropper

Chairman

 

Enquiries:

John Denman, Group Finance Director

Richard Baty, Paul Gillam

James Cropper PLC

Westhouse Securities Limited

Tel: 01539 722002

Tel: 0207 601 6100

www.cropper.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMEANXFDSFDEEF
Date   Source Headline
12th Mar 20243:06 pmRNSDirector/PDMR Shareholding
8th Mar 20242:25 pmRNSDirector/PDMR Shareholding
17th Jan 20247:00 amRNSTrading Update
12th Jan 20247:00 amRNSDirectorate Update
21st Dec 20233:33 pmRNSDirector/PDMR Shareholding
20th Dec 20237:00 amRNSGrant of Awards under Long Term Incentive Plan
27th Nov 20237:00 amRNSBoard Appointment
24th Nov 20232:30 pmRNSDirectorate Change
9th Nov 20237:00 amRNSInterim Results
26th Oct 20237:00 amRNSNotice of Interim Results
26th Sep 20232:50 pmRNSResult of Annual General Meeting
26th Sep 20237:00 amRNSAGM Trading Update
4th Sep 20237:00 amRNSNotice of AGM
31st Aug 20237:00 amRNSInnovative production unit for green hydrogen
29th Aug 202312:43 pmRNSDividend Declaration
24th Aug 20237:00 amRNSFull Year Results
10th Aug 20237:00 amRNSNotice of Full Year Results
14th Jun 20237:00 amRNSDirectorship Change
7th Jun 20237:00 amRNSTFP HYDROGEN ANNOUNCES EXPANSION IN NORTH AMERICA
21st Apr 20235:18 pmRNSDirector/PDMR Shareholding
19th Apr 20237:00 amRNSTrading Update and Overview of Strategy
14th Feb 202312:00 pmRNSDirector/PDMR Shareholding
1st Feb 20237:00 amRNSDirector/PDMR Shareholding
31st Jan 20239:45 amRNSDirector/PDMR Shareholding
2nd Dec 20227:00 amRNSDirector/PDMR Shareholding
18th Nov 20229:48 amRNSDirector/PDMR Shareholding
15th Nov 20227:00 amRNSHalf-year Report
31st Oct 20227:00 amRNSHalf Year Trading Update
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
12th Sep 202211:03 amRNSDirector/PDMR Shareholding
2nd Sep 20224:40 pmRNSSecond Price Monitoring Extn
2nd Sep 20224:35 pmRNSPrice Monitoring Extension
26th Aug 20227:00 amRNSDirector/PDMR Shareholding
10th Aug 20227:00 amRNSDirectorship Change
5th Aug 202211:45 amRNSDirector/PDMR Shareholding
27th Jul 202211:00 amRNSQ1 Trading Update and AGM Statement
19th Jul 20227:00 amRNSDirector/PDMR Shareholding
8th Jul 202210:34 amRNSDirector/PDMR Shareholding
7th Jul 20227:00 amRNSDirector/PDMR Shareholding
23rd Jun 202210:25 amRNSNotice of AGM and Annual Report & Accounts
21st Jun 20227:00 amRNSFinal Results
12th May 202212:01 pmRNSHolding(s) in Company
24th Mar 20227:00 amRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSTrading Update
26th Jan 20222:30 pmRNSDirector/PDMR Shareholding
21st Jan 202212:15 pmRNSDirector/PDMR Shareholding
20th Jan 202210:30 amRNSDirectorate Change
12th Jan 20222:00 pmRNSCorrection to Director/PDMR Shareholding
12th Jan 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.